Firdouse Mohammed, Wajchendler Amy, Koyle Martin, Fecteau Annie
Faculty of Medicine, University of Toronto, Toronto, ON.
York University, Toronto, ON.
J Pediatr Surg. 2017 May;52(5):859-863. doi: 10.1016/j.jpedsurg.2017.01.023. Epub 2017 Jan 28.
The purpose of this study was to develop and validate a checklist to standardize surgical informed consent process.
A checklist was created following a literature search. Consent processes were observed from general surgery (GS) and urology (US) in the pre- and post-intervention phases. Competent patients/guardians were asked to complete a satisfaction questionnaire. All trainees and staff surgeons were interviewed on the checklist's utility.
73 observations (GS=39, US=34) and 66 observations (GS=30, US=36) were made in the pre- and post-intervention phase, respectively. Our checklist increased the frequency with which surgeons explained alternative treatments (pre-intervention 23.3% vs. post-intervention 81.8%), the role of trainees (15.1% vs. 72.7%), and the potential outcomes of not pursuing surgery (60.3% vs. 87.9%). The patient/guardian average satisfaction score increased between phases within GS (mean[standard deviation] 3.55[0.58] vs. 3.85[0.24]); p=0.002), but not within US (3.53[0.61] vs. 3.52[0.54]); p=0.705) or the overall sample (3.54[0.59] vs. 3.67[0.46]); p=0.329). Interestingly, there was no significant improvement in patient/guardian average anxiety levels in GS (X=0.069, p=0.793), US (X=0, p=1) or the overall sample (X=0.143, p=0.706) following the intervention.
Our checklist aids in standardizing the informed consent process. However, it did not significantly change satisfaction or anxiety levels of patients and guardians.
Prognosis study.
Level III.
本研究旨在制定并验证一份用于规范手术知情同意流程的清单。
在文献检索后创建了一份清单。在干预前和干预后阶段观察普通外科(GS)和泌尿外科(US)的同意流程。要求有行为能力的患者/监护人填写一份满意度调查问卷。就清单的实用性对所有实习医生和外科 staff 进行了访谈。
干预前和干预后阶段分别进行了73次观察(GS = 39,US = 34)和66次观察(GS = 30,US = 36)。我们的清单提高了外科医生解释替代治疗的频率(干预前23.3% 对干预后81.8%)、实习医生的角色(15.1% 对72.7%)以及不进行手术的潜在后果(60.3% 对87.9%)。GS组内患者/监护人的平均满意度得分在各阶段之间有所提高(平均值[标准差]3.55[0.58]对3.85[0.24];p = 0.002),但US组内未提高(3.53[0.61]对3.52[0.54];p = 0.705),总体样本中也未提高(3.54[0.59]对3.67[0.46];p = 0.329)。有趣的是,干预后GS组(X = 0.069,p = 0.793)、US组(X = 0,p = 1)或总体样本(X = 0.143,p = 0.706)中患者/监护人的平均焦虑水平均无显著改善。
我们的清单有助于规范知情同意流程。然而,它并未显著改变患者和监护人的满意度或焦虑水平。
预后研究。
三级。